No Data
No Data
Earnings Preview: Oculis to Report Financial Results Pre-market on November 07
Oculis Holding AG's (NASDAQ:OCS) Largest Shareholders Are Individual Investors With 56% Ownership, Institutions Own 39%
Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last?
Oculis Holding Analyst Ratings
Oculis Holding Gains 'Buy' Rating Amid Promising Clinical Trial Advancements and Pipeline Potential
Oculis Shares Are Trading Higher After the Company Announced It Expanded Its DIAMOND Program With Global Retina Experts and Is Accelerating Its Phase 3 Trials for DME Treatment.
No Data
No Data
ricko : this should pop according to the news